tirzepatide for lupus and lupus: what SLE patients need to know Lilly Shows Tirzepatide Superiority in

Satiety The feeling of fullness that occurs after eating

What happens in MS * Immune system damages myelin * Forms sclerosis (scar plaques) * Slows or blocks nerve impulses * Leads to neurological dysfunction depending on location Common symptoms Symptoms vary widely depending on which nerves are affected: Motor & sensory * Weakness in limbs * Numbness or tingling * Loss of coordination (ataxia) * Muscle stiffness (spasticity) Visual * Optic neuritis (painful vision loss, blurred vision) * Double vision Other * Fatigue (very common) * Bladder or bowel dysfunction * Cognitive changes (memory, attention problems) * Electric shock sensation down spine when bending neck (Lhermitte sign) Types of MS * Relapsing-remitting MS (RRMS): attacks followed by recovery (most common) * Secondary progressive MS (SPMS): starts relapsing, then slowly worsens * Primary progressive MS (PPMS): steady worsening from onset Causes & risk factors Exact cause is unknown, but involves: * Autoimmune dysfunction * Genetic predisposition * Viral triggers (e.g., Epstein-Barr virus association) * Low vitamin D / less sunlight exposure * More common in young adults and females Diagnosis No single testcombination of: * MRI brain/spine: shows demyelinating plaques * Lumbar puncture: oligoclonal bands in CSF * Evoked potential tests (nerve conduction delays) * Clinical history of dissemination in time and space Treatment There is no cure, but treatment slows progression and controls relapses: Disease-modifying therapy * Interferon beta-1a * Glatiramer acetate * Ocrelizumab Relapse treatment * High-dose corticosteroids (e.g., methylprednisolone) Symptom management * Muscle relaxants for spasticity * Physiotherapy and rehabilitation * Fatigue management strategies Complications * Progressive disability * Mobility problems * Vision impairment * Cognitive decline in advanced stages MS is a misdirected immune attack on nerve insulation nerve signals slow down or fail neurological symptoms appear in unpredictable patterns

In 2020, Wilson embarked on a weight loss journey

In a study published in the New England Journal of Medicine , participants using Semaglutide lost up to 15% of their body weight over 68 weeks, compared to 2.4% in the placebo group

Adults with a BMI of 30+ , OR Adults with a BMI of 27+ plus at least one weight-related condition (e.g., hypertension, diabetes, high cholesterol) This treatment requires a medical evaluation and prescription from a licensed healthcare provider